✦ LIBER ✦

Irinotecan and cisplatin with concurrent thoracic radiotherapy in a once-every-three-weeks schedule in patients with limited-disease small-cell lung cancer: A phase I study

✍ Scribed by de Jong, W.K.; de Jonge, M.J.A.; van der Leest, A.H.D.; van Meerbeeck, J.P.; Groen, H.J.M.

Book ID: 119319825
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 138 KB
Volume: 61
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2007.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

✍ M Oka; M Fukuda; M Kuba; M Ichiki; T Rikimaru; H Soda; J Tsurutani; Y Nakamura; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy (TRT) in limited-stage small cell lung cancer (LS-SCLC)

✍ Fukuda, M; Kinoshita, A; Kuba, M; Ichiki, M; Rikimaru, T; Takatani, H; Fukuda, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Phase II study of irinotecan plus cispla

Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer

✍ Jeong, Hye Cheol; Lee, Sang Yeub; Lee, Sung Yong; Kim, Je Hyeong; Shin, Chol; Sh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

Simultaneous chemoradiotherapy with irin

Simultaneous chemoradiotherapy with irinotecan and cisplatin in limited disease small cell lung cancer: A phase I study

✍ Klautke, Gunther; Fähndrich, Sebastian; Semrau, Sabine; Büscher, Claudia; Vircho 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 112 KB

A phase II study of a 3-day schedule wit

A phase II study of a 3-day schedule with topotecan and cisplatin every three weeks in patients with previously intreated small cell lung cancer and extensive disease

✍ Lassen, Ulrik N.; Sorensen, Morten; Jensen, Peter Buhl; Langer, Seppo W.; Jensen 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 190 KB